ANTERIS TECHNOLOGIESLOGIES Share · AU0000088841 · AVR · A2P5AF (XASX) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of ANTERIS TECHNOLOGIESLOGIES

No Price

01.05.2026 23:01

Current Prices from ANTERIS TECHNOLOGIESLOGIES

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	AVR	USD	01.05.2026 23:01	6,16 USD	0,010 USD +0,16 %
NASDAQ	AVR	AUD	01.05.2026 20:00	6,36 AUD	0,21 AUD +3,41 %
IEX	AVR	USD	01.05.2026 19:59	6,36 USD	0,21 USD +3,41 %

Company Profile for ANTERIS TECHNOLOGIESLOGIES Share

Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.